Light microscopy study of cisplatin-induced ototoxicity in rats

Journal of Laryngology and Otology

Volumn 123, Issue 6, 2009, Pages 590-597

  De Freitas, M R ^a   De Castro Brito, G A ^a   De Carvalho Jr , J V ^a   Gomes Jr , R M ^a   Barreto Martins, M J ^a   De Albuquerque Ribeiro, R ^a  

^a FEDERAL UNIVERSITY OF CEARÁ   (Brazil)

Author keywords

Cisplatin; Drug toxicity; Inner ear; Microscopy

Indexed keywords

CISPLATEX; CISPLATIN; EOSIN; HEMATOXYLIN; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

AMPLITUDE MODULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CILIATED EPITHELIUM; COCHLEA; CONTROLLED STUDY; DISTORTION PRODUCT OTOACOUSTIC EMISSION; FUNCTIONAL ASSESSMENT; HISTOCHEMISTRY; HISTOPATHOLOGY; MALE; MICROSCOPY; NONHUMAN; OTOTOXICITY; RAT; SCORING SYSTEM; TISSUE STRUCTURE; WISTAR RAT;

ANIMALS; CISPLATIN; COCHLEA; HEARING LOSS; MALE; MICROSCOPY, POLARIZATION; OTOACOUSTIC EMISSIONS, SPONTANEOUS; RATS; RATS, WISTAR; REFERENCE VALUES;

EID: 68049135490     PISSN: 00222151     EISSN: 17485460     Source Type: Journal    
DOI: 10.1017/S0022215109004319     Document Type: Article

References (26)

1. Oliveira JAA, Canedo DM, Rossato M. Otoprotection of auditory hair cells against amikacin ototoxicity. Rev Bras Otorrinolaringol 2002;68:7-13
2. Jordan JA, Schwade ND, Truelson JM. Fosfomycin does not inhibit the tumoricidal efficacy of cisplatinum. Laryngoscope 1999;109:1259-62
3. Güneri EA, Serbetçiogllu B, Ikiz AO, Güneri A, Ceryan K. TEOAE monitoring of cisplatin induced ototoxicity in guinea pigs: the protective effect of vitamin B treatment. Auris Nasus Larynx 2001;28:9-14
4. Feghali JG, Liu W, Water TRVD. L-N-acetyl-cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity. Laryngoscope 2001;111:1147-55
5. Campbell KCM, Rybac LP, Meech RP. D-Methionine provides excellent protection from cisplatin ototoxicity in the rat. Hear Res 1996;102:90-8
6. Kamimura T, Whitworth CA, Rybak LP. Effect of 4-methylthiobenzoic acid on cisplatin-induced ototoxicity in the rat. Hear Res 1999;131:117- 27
7. Li G, Frenz DA, Brahmblatt S, Feghali JG, Ruben RJ, Berggren D et al. Round window membrane delivery of l-methionine provides protection from cisplatin ototoxicity without compromising chemotherapeutic efficacy. Neurotoxicology 2001;22:163-76
8. Tanaka F, Whitworth CA, Rybak LP. Round window pH manipulation alters the ototoxicity of systemic cisplatin. Hear Res 2004;187:44-50
9. Kalkanis JK, Whitworth MA, Rybak LP. Vitamin E reduces cisplatin ototoxicity. Laryngoscope 2004;114:538-42
10. Fetoni AR, Quaranta N, Marchese R, Cadoni G, Paludetti G, Sergi B. The protective role of tiopronin in cisplatin ototoxicity in Wistar rats. Int J Audiol 2004;43:465-70
11. Campbell KCM, Meech RP, Rybak LP, Hughes LF. D-Methionine protects against cisplatin damage to the stria vascularis. Hear Res 1999;138:13-28
12. Laurell G, Viberg A, Teixeira M, Sterkers O, Ferrary E. Blood-perilymph barrier and ototoxicity: an in vivo study in rat. Acta Otolaryngol 2000;120:796-803
13. (4-9) analogue, ORG 2766, may reduce the cochleotoxic effects of cisplatin. Hear Res 1997;106:9-19
14. Heijmen PS, Klis SFL, De Groot JCMJ, Smoorenburg GF. Cisplatin ototoxicity and the possibily protective effect of α-melanocyte stimulating hormone. Hear Res 1999;128: 27-39
15. Cardinaal RM, De Groot JCMJ, Huizing EH, Veldman JE, Smoorenburg GF. Dose-dependent effect of 8-day cisplatin administration upon the morphology of the albino guinea pig cochlea. Hear Res 2000;144:135-46
16. Cardinaal RM, De Groot JCMJ, Huizing EH, Veldman JE, Smoorenburg GF. Cisplatin-induced ototoxicity: morphological evidence of spontaneous outer hair cell recovery in albino guinea pig? Hear Res 2000;144:147-56
17. 4-9 analogue, ORG 2766, on cisplatin ototoxicity in the albino guinea pig. Hear Res 2000;144:157-67
18. Sergi B, Ferraresi A, Troiani D, Paludetti G, Fetoni AR. Cisplatin ototoxicity in the guinea pig: vestibular and cochlear damage. Hear Res 2003;182:56-64
19. Lynch ED, Gu R, Pierce C, Kil J. Reduction of acute cisplatin ototoxicity and nephrotoxicity in rats by oral administration of allopurinol and ebselen. Hear Res 2005;201:81-9
20. Wang RV, Faulconbridge RVL, Fetoni A, Guitton MJ, Pujol R, Puel JL. Local application of sodium thiosulfate prevents cisplatin-induced hearing loss in the guinea pig. Neuropharmacology 2003;45:380-93
21. Smoorenburg GF, De Groot JCMJ, Hamers FPT, Klis SFL. Protection and spontaneous recovery from cisplatin-induced hearing loss. Ann N Y Acad Sci 1999;28:192-210
22. O'Leary SJ, Klis SFL, De Groot JCMJ, Hamers FPT, Smoorenburg GF. Perilymphatic application of cisplatin over several days in albino guinea pigs: dose dependency of electrophysiological and morphological effects. Hear Res 2001;154:135-45
23. Sluyter S, Klis SFL, De Groot JCMJ, Smoorenburg GF. Alterations in the stria vascularis in relation to cisplatin ototoxicity and recovery. Hear Res 2003;185:49-56
24. Wolters FLC, Klis SFL, Hamers FPT, De Groot JCMJ, Smoorenburg GF. Perilymphatic application of α-melanocyte stimulating hormone ameliorates hearing loss caused by systemic administration of cisplatin. Hear Res 2004;189:31-40
25. Van Ruijven MWM, De Groot JCMJ, Smoorenburg GF. Time sequence of degeneration pattern in the guinea pig cochlea during cisplatin administration. A quantitative histological study. Hear Res 2004;197:44-54
26. Van Ruijven MWM, De Groot JCMJ, Klis SFL, Smoorenburg GF. The cochlear targets of cisplatin: an electrophysiological and morphological time-sequence study. Hear Res 2005;205:241-8